Dyslipidemia Therapy
from NP Certification Q&A Hosted by Fitzgerald Health Education Associates
A 65-year-old woman has hypertension, dyslipidemia, type 2 diabetes, a 50 pack-year history of cigarette smoking, currently smoking ½ PPD, and stage 3B chronic kidney disease (CKD) (GFR = 37 mL/min/1.73 m2). She is not currently taking any dyslipidemia therapy and her LDL= 140 mg/dL. Which of the following represents the most appropriate pharmacologic intervention for treatment of dyslipidemia? A. Owing to her age and comorbidity, no further intervention is required. B. Moderate-intensity statin therapy is the preferred treatment option. C. Niacin should be prescribed. D. The use of ezetimibe (Zetia®) will likely be sufficient to achieve dyslipidemia control. --- YouTube: https://www.youtube.com/watch?v=up_iIweB9Ic&list=PLf0PFEPBXfq592b5zCthlxSNIEM-H-EtD&index=27 Visit fhea.com to learn more!
Embed this episode
What this episode covers
A 65-year-old woman has hypertension, dyslipidemia, type 2 diabetes, a 50 pack-year history of cigarette smoking, currently smoking ½ PPD, and stage 3B chronic kidney disease (CKD) (GFR = 37 mL/min/1.73 m2). She is not currently taking any dyslipidemia therapy and her LDL= 140 mg/dL. Which of the following represents the most appropriate pharmacologic intervention for treatment of dyslipidemia? A. Owing to her age and comorbidity, no further intervention is required. B. Moderate...
No transcript yet.